相关实验视频

Updated: Jan 7, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

化学抗原受体T细胞疗法和针对大型B细胞淋巴瘤的双特异性抗体序列:系统性审查和元分析

Mark Sorin1, Rakan Okde2, Merrik Goulet3

  • 1Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Québec, Canada; Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.

The Lancet. Haematology
|December 25, 2025
PubMed
概括

在嵌合式抗原受体T细胞疗法 (CAR-T) 之前给予双特异性抗体 (BsAb) 可能会增强大型B细胞淋巴瘤的CAR-T疗效. 这一序列显示出有希望的结果,尽管由于样本大小小小,需要进一步研究.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.7K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.8K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K